BCL2 and hematopoietic and lymphoid cell neoplasm: The interaction between miR-15a-5p and BCL2 was first characterized in hematologic cancers, particularly chronic lymphocytic leukemia (CLL), where loss of miR-15a/16-1 leads to BCL2 overexpression and impaired apoptosis.